July 8, 2008 — Greatbatch, Inc. and Integrated Sensing Systems, Inc. (ISSYS) have entered into an agreement to collaboratively develop miniature wireless implantable sensing solutions to be commercialized in partnership with OEM medical device manufacturers servicing the cardiac rhythm management (CRM), neurosurgical, neuromodulation, ophthalmology and orthopedic markets.
The companies plan to design, develop and manufacture solutions, which include sensors and delivery products, to support targeted markets enabling the advancement of patient care. These products will enhance the treatment of clinical indications such as congestive heart failure, traumatic brain injury and glaucoma.

“Our technology partnership allows us to broaden our product offering and market presence by bringing innovation to the forefront and enabling our OEM partners to address unmet patient needs,” says Mauricio Arellano, senior vice president of Greatbatch’s CRM & Neuromodulation business. “Additionally, these sensor technologies complement our recent expansion into vascular delivery tools.”

Dr. Nader Najafi, ISSYS CEO, adds: “The synergy of ISSYS’ wireless implantable MEMS sensing technology and Greatbatch’s expertise within the implantable medical markets will speed the introduction of these novel miniature wireless implantable products within broader emerging medical markets.”